First-in-human phase 1 trial of ELI-002 immunotherapy as treatment for subjects with Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma and other solid tumors Meeting Abstract
| Authors: | Pant, S.; Furqan, M.; Abdul-Karim, R. M.; Chung, V.; Devoe, C. E.; Johnson, M. L.; Leal, A. D.; Park, H.; Wainberg, Z. A.; Welkowsky, E.; Haqq, C. M.; O'Reilly, E. M.; Weekes, C. D. |
| Abstract Title: | First-in-human phase 1 trial of ELI-002 immunotherapy as treatment for subjects with Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma and other solid tumors |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304865 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS2701 |
| Notes: | Meeting Abstract: TPS2701 -- Meeting also held virtually -- Source: Wos |
